Suppr超能文献

间歇阻断肝门血流操作是否会影响肝细胞癌切除术后的复发?一项系统综述。

Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review.

机构信息

Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.

The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

出版信息

PLoS One. 2020 Mar 11;15(3):e0229870. doi: 10.1371/journal.pone.0229870. eCollection 2020.

Abstract

BACKGROUND AND AIM

To evaluate the effect of intermittent pringle maneuver (IPM) on the long-term prognosis and recurrence of hepatocellular carcinoma (HCC).

METHODS

Eligible studies were identified by PubMed and other databases from Jan 1st 1990 to Mar 31st 2019. Hazard ratios (HR) with 95% confidence interval (CI) were calculated to evaluate the effects of IPM on the long-term prognosis and recurrence of patients with HCC.

RESULTS

Six studies were enrolled in this meta-analysis. Results showed that there were no differences between IPM group and non-IPM group in the pooled HRs for the overall survival (OS) and disease-free survival (DFS) (HR 1.04, 95%CI 0.841.28, P = 0.74; HR 0.93, 95%CI 0.811.07, P = 0.29; respectively). However, subgroup analysis showed that the pooled Odd ratios (OR) for the 1-year OS and DFS rates of the IPM group when compared with the non-IPM group were 0.65 (95% CI 0.450.94, P = 0.02), 0.38 (95% CI 0.200.72, P = 0.003), respectively. In addition, there were no significant differences in the proportions of liver cirrhosis, HBsAg (+), Child-Pugh A class, multiple tumor, vascular invasion, and major hepatectomy between groups of IPM and non-IPM.

CONCLUSION

Since IPM would increase the risk of early-recurrence, it should be used cautiously in the procedure of hepatectomy for resectable HCC. However, the current conclusion needs further validation.

TRIAL REGISTRY NUMBER

CRD 42019124923.

摘要

背景与目的

评估间歇阻断入肝血流(IPM)对肝细胞癌(HCC)长期预后和复发的影响。

方法

通过 PubMed 和其他数据库,自 1990 年 1 月 1 日至 2019 年 3 月 31 日,检索相关文献,评估 IPM 对 HCC 患者长期预后和复发的影响。

结果

本荟萃分析纳入 6 项研究。结果显示,IPM 组和非 IPM 组的总生存(OS)和无病生存(DFS)的汇总 HR 无显著差异(HR 1.04,95%CI 0.841.28,P = 0.74;HR 0.93,95%CI 0.811.07,P = 0.29)。然而,亚组分析显示,与非 IPM 组相比,IPM 组 1 年 OS 和 DFS 率的汇总 OR 分别为 0.65(95%CI 0.450.94,P = 0.02)和 0.38(95%CI 0.200.72,P = 0.003)。此外,两组间肝硬化、HBsAg(+)、Child-Pugh A 级、多发肿瘤、血管侵犯和大肝切除的比例无显著差异。

结论

虽然 IPM 会增加早期复发的风险,但在可切除 HCC 的肝切除术中应谨慎使用。然而,目前的结论还需要进一步验证。

临床试验注册号

CRD 42019124923。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验